HanAll Biopharma Major Shareholder Ownership Increases 0.04%
-
Major shareholder holdings increased by 21,288 shares (0.04%p) to 31.28% (previously 31.24%)
-
Increase due to executives exercising stock options (Park Seung-guk 13,334 shares, Jung Seung-won 32,334 shares)
-
Jung Seung-won sold 24,380 shares on market but net increase
-
Largest shareholder Daewoong Pharmaceutical unchanged at 30.85%
KOSPI Filing Information
-
Filing: Report on Change in Ownership of Major Shareholders, etc.
-
Company: Hanall Biopharma (009420)
-
Submission: Hanall Biopharma Co., Ltd.
-
Receipt: 05-06-2026
-
Under KRX KOSPI Market Division